Bank of America
APTO

Bank of America’s Aptose Biosciences, Inc. APTO Stock Holding History

Bank of America’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$110 – 8593
2024
Q1 		$110 Sell
2
-1
-33% -$57 ﹤0.01% 7388
2023
Q4 		$254 Sell
3
-44
-94% -$3.41K ﹤0.01% 7344
2023
Q3 		$3.92K Buy
47
+44
+1,467% +$5.18K ﹤0.01% 7046
2023
Q2 		$464 Buy
+3
New +$621 ﹤0.01% 7326
2023
Q1 		– Sell
-1
Closed -$290 – 8506
2022
Q4 		$290 Buy
+1
New +$269 ﹤0.01% 7490
2022
Q3 		– Hold
0
– – – 8398
2022
Q2 		– Hold
0
– – – 8641
2022
Q1 		– Hold
0
– – – 9002
2021
Q4 		– Hold
0
– – – 8859
2021
Q3 		– Hold
0
– – – 8537
2021
Q2 		– Sell
-56
Closed -$149K – 8254
2021
Q1 		$149K Buy
56
+55
+5,500% +$109K ﹤0.01% 6226
2020
Q4 		$1K Sell
1
-103
-99% -$242K ﹤0.01% 7037
2020
Q3 		$281K Buy
104
+82
+373% +$204K ﹤0.01% 5092
2020
Q2 		$61K Buy
+22
New +$71K ﹤0.01% 5887
2019
Q3 		– Hold
0
– – – 7608
2019
Q2 		– Hold
0
– – – 7503
2019
Q1 		– Sell
-2
Closed -$2K – 7504
2018
Q4 		$2K Buy
2
+1
+100% +$984 ﹤0.01% 6921
2018
Q3 		$1K Sell
1
-9
-90% -$12.1K ﹤0.01% 7174
2018
Q2 		$17K Buy
10
+9
+900% +$14.3K ﹤0.01% 6557
2018
Q1 		$2K Buy
+1
New +$1.34K ﹤0.01% 6920
2017
Q4 		– Sell
-1
Closed – – 7332
2017
Q3 		$0 Buy
+1
New +$671 ﹤0.01% 7350
2017
Q2 		– Sell
-1
Closed – – 7254
2017
Q1 		$0 Sell
1
-10
-91% -$5.13K ﹤0.01% 7321
2016
Q4 		$7K Sell
11
-2
-15% -$1.25K ﹤0.01% 6644
2016
Q3 		$14K Buy
+13
New +$13.5K ﹤0.01% 6271
2016
Q2 		– Sell
-2
Closed -$3K – 7474
2016
Q1 		$3K Buy
+2
New +$2.39K ﹤0.01% 6719
2015
Q2 		– Sell
-2
Closed -$4K – 7469
2015
Q1 		$4K Buy
+2
New +$4.83K ﹤0.01% 6575

Other funds holding APTO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Bank of America's APTO Position: Q2 2024 in Review

Bank of America sold out of Aptose Biosciences, Inc. (APTO) in Q2 2024, closing a stake of 2 shares — an estimated $110 sold.

Bank of America first reported a position in APTO in Q1 2015 and held it in 19 quarters. The position peaked at $281K in Q3 2020. 20 funds tracked by Wall St. Rank hold APTO as of Q2 2024.

  • Bank of America reported no remaining Aptose Biosciences, Inc. position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 2 Aptose Biosciences, Inc. shares in Q2 2024, an estimated $110.
  • Bank of America first reported a position in Aptose Biosciences, Inc. in Q1 2015 and held it in 19 quarters.
  • Bank of America's Aptose Biosciences, Inc. position peaked at $281K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.